BC Platforms, a provider of genomic data management and analytics has announced the appointment of Richard Kivel as its Chairman
Agilent Technologies has announced that it has signed an agreement to acquire Lasergen
ID Genomics (IDG), a Seattle-based, developer of rapid point-of-care diagnostics, has announced the discovery of a nationwide rise in the levels of a drug-resistant ‘superbug’ - Escherichia coli strain ST1193
Robert Roe reports on the Paperless Lab Academy event on the potential impact of disruptive technologies such as blockchain and IoT in the laboratory
At The Pistoia Alliance’s annual EU member conference in London, president of the Pistoia Alliance, Dr Steve Arlington, urged stakeholders to come together to help technology continue to drive change in the industry and to amplify R&D budgets
A web-based tool to promote the sharing of research reagents and information can help tackle the crisis in reproducibility in life-science research, argues Isobel Atkin.
Certara, the global leader in model-informed drug development and regulatory science, today announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium
Citoxlab Group, which offers a range of preclinical and specialty services, has announced it attends to acquire Solvo Biotechnology
Agilent TechnologiesandImperial College London have signed a strategic scientific collaboration agreement that brings together Agilent’s analytical technologies with Imperial researchers
Two reports published in Biological Psychiatry demonstrate an approach to use electronic health records to more accurately investigate neuropsychiatric symptoms.
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
